The Neuroendovascular Coil Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Neuroendovascular Coil Market:
https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report
According to The Business Research Company’s Neuroendovascular Coil Global Market Report 2024, The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.18 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.
The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research.. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.
The growing prevalence of neurovascular diseases is expected to propel the growth of the neuroendovascular coil market going forward. Neurovascular diseases affect the blood vessels supplying the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used in treating neurovascular diseases by being inserted into blood vessels to block off or stabilize abnormal blood vessel structures, reducing the risk of bleeding or other complications. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, stroke deaths increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. Further, each year, there are more than 795,000 strokes in the United States, among which 610,000 are first-time strokes. Therefore, the growing prevalence of neurovascular diseases is driving the growth of the neuroendovascular coil market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13495&type=smp
The neuroendovascular coil market covered in this report is segmented –
1) By Product Type: Guglielmi Detachable Coils (GDCs) , Matrix Coils
2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm
3) By Application: Tumor Surgery, Medical Teaching
4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users
Major companies operating in the neuroendovascular coil market are focused on developing soft and unique-shaped coils to gain a competitive edge in the market. In neuroendovascular procedures, soft and unique shapes, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, especially in complex cases. For instance, in December 2022, Stryker Corporation, a US-based medical technology company that manufactures neuroendovascular coils, launched the Target Tetra Detachable Coil, which combines a new tetrahedral shape and softness level and is specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that allows stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory and is soft at the same time, making it a good choice for treating small aneurysms.
The neuroendovascular coil market report table of contents includes:
1. Executive Summary
2. Neuroendovascular Coil Market Characteristics
3. Neuroendovascular Coil Market Trends And Strategies
4. Neuroendovascular Coil Market – Macro Economic Scenario
5. Global Neuroendovascular Coil Market Size and Growth
.
.
.
26. South America Neuroendovascular Coil Market
27. Brazil Neuroendovascular Coil Market
28. Middle East Neuroendovascular Coil Market
29. Africa Neuroendovascular Coil Market
30. Neuroendovascular Coil Market Competitive Landscape And Company Profiles
Top Major Players:
- Cardinal Health Inc
- Johnson & Johnson Services Inc
- Medtronic PLC
- Stryker Corporation
- Boston Scientific Corporation
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
